Searchable abstracts of presentations at key conferences in endocrinology

ea0026p597 | Clinical case reports | ECE2011

Use of our last pills of iopanoic acid in a 33-year-old patient in acute refractory pulmonary edema and thyroid storm: requiem for a useful therapeutic agent

Hoyos E Gomez , Novoa P de Miguel , Zorrilla C Montanez , de la Torre N Garcia , Freixes M Curras , Freire R Bover , Pascual A Calle , de la Vega I Runkle

Introduction: The contrast agents iopanoic acid and ipodate are potent inhibitors of thyroid function, reducing type I deodinase T3 generation, inhibiting thyroid liberation of T4 and T3, and T3 receptor binding, with off-label use in hyperthyroid emergencies. However, since the interruption of iopanoic acid production this year, neither agent is currently available in Spain.Case report: A 34-year-old male was ...

ea0021p279 | Pituitary | SFEBES2009

Echocardiography in patients with hyperprolactinaemia treated with dopamine agonists: what happens in daily clinical practice and what are the findings?

Soo Audrey , Baldeweg Stephanie E

Background: Ergot-derived dopamine agonist therapy (EDDAT) is associated with cardiac valvulopathy in Parkinson’s disease. The risk to patients with prolactinomas is uncertain. The EMEA/MRHA and BSE recently issued guidelines for surveillance echocardiography (ECHO) of patients receiving treatment with EDDAT. Our policy is to arrange opportunistic ECHO screening at first clinic visit guidelines.Objective: We investigated the uptake and findings of e...

ea0081ep1161 | Thyroid | ECE2022

Case report: Amiodarone-induced thyroid dysfunction

Akid Faten Haj Kacem , Trimeche Oumeyma , Missaoui AbdelMouhaymen , Salah Dhoha Ben , Fatma Mnif , Charfi Nadia , Mnif Mouna , Majdoub Nabila Rekik , Elleuch Mouna , Abid Mohamed

Amiodarone is considered by many the most potent antiarrhythmic drug. The other side of the coin is that it’s associated with many side effects including disturbances in the thyroid function, which can be seen in 14 to 18 % of the cases (1). This case is about a 56-year-old male patient with a history of mitral valve disease who was on Amiodarone for 3 years. His personal history was notable with Epilepsy of unknow etiology for which he was on sodium valproate. During fol...

ea0015p219 | Pituitary | SFEBES2008

Low dose cabergoline in hyperprolactinaemia is not associated with clinically significant valvular heart disease

Wakil Ammar , Clark Andrew , Atkin Stephen

Introduction: Recent trials suggest that using ergot-derived dopamine agonists such as cabergoline in the treatment of Parkinson’s disease is associated with an increased risk of valvular heart disease. However, the dose of cabergoline used to treat hyperprolactinaemia is considerably less than that used in Parkinson’s disease.Study design: A cross-sectional study; forty four patients, who received cabergoline for at least 6 months, underwent t...

ea0090ep759 | Pituitary and Neuroendocrinology | ECE2023

Endocrinopathy behind the facemask – follow up

Nyunt Sandhi , Sharma Aditi , Narula Kavita , Mitchell Catherine , Mendoza Nigel , Ling Yong Yong , Hatfield Emma , Meeran Karim , Martin Niamh

A 44-year-old gentleman presented to the Emergency Department with a 2-week history of fever and rigors. Past medical history was unremarkable other than an earlier diagnosis of hypertension. He was noted to have new onset atrial fibrillation with rapid ventricular response; a diagnosis of hypertrophic obstructive cardiomyopathy (HOCM) was made on echocardiography. In addition, a vegetation was identified on the mitral valve. Treatment for infective endocarditis (Streptoco...

ea0063p371 | Thyroid 1 | ECE2019

Navigating thyroid storm: The role of plasmapheresis in a patient also needing urgent aortic valve replacement surgery

Parihar Richa , Hull Stephen

Thyroid storm requires a multiple-step pharmacological approach. While there is limited evidence for it, plasmapheresis has been shown to be an effective treatment when patients fail conventional therapy and other comorbidities complicate the clinical course. A 65-year-old woman presented with 6 months of symptoms of thyrotoxicosis and dyspnea, treated initially as an outpatient for pneumonia with no improvement. Eventually requiring admission for her dyspnea, laboratory testi...

ea0041gp58 | Cardiovascular endocrinology | ECE2016

Cardiac status after long-term growth hormone replacement therapy in adult growth hormone deficient patients. A single centre audit based on echocardiographic investigations before and during GH replacement therapy

Skoglund Sissela , Rasmussen Ulla Feldt , Klose Marianne , Hassager Christian

Objective: To determine the effects of long-term growth hormone (GH) treatment on heart anatomy and function among adult GH deficient patients.Design: A retrospective observational study at Copenhagen University Hospital, Rigshospitalet, Denmark between 1999 and 2015.Patients: All patients with available echocardiography data at treatment baseline, 3–5 years and 8–10 years follow up. We included 25 naïve GH deficient...

ea0063p404 | Thyroid 1 | ECE2019

Pancytopenia and reversible cardiomyopathy - complications of thyrotoxicosis: case report

Klimaite Raimonda , Kinderyte Marija , Dauksaite Neda , Barsiene Lina , Zilaitiene Birute

Introduction: Grave’s disease is frequently associated with cytopenia. Pancytopenia, however, is rare. Thyroid hormones have a direct effect on myocardial contractility and left ventricle (LV) diastolic function. Only less than 1% of the patients with hyperthyroidism develop cardiomyopathy with impaired left ventricular systolic function.Case: A 51-year old woman was admitted to the Hospital of Lithuanian University of Health Sciences, Kaunas clinic...

ea0051p055 | Pituitary and growth | BSPED2017

Long-term unidentified complication of IGF-I treatment: Pulmoner hypertension

Akinci Aysehan , Dundar Ismail , Karakurt Cemsit

In this report, we described pulmonary hypertension (PH) in two patients with growth hormone insensitivity (GHI) who are taking IGF-I(increlex) for along time.Case 1: 6-year-old male patient who has been followed for 4 years with the diagnosis of GHI. He was admitted to the hospital with the complaints of hypoglycemia and severe short stature (height SDS: −7.4). His physical examination, laboratory findings(GH>40 μg/dl, IGF-IA homozygous m...

ea0081ep890 | Reproductive and Developmental Endocrinology | ECE2022

Klinefelter syndrome associated with intellectual deficit, short stature and cardiac anomalies

Hasni Yosra , Farid Hayfa , Elfekih Hamza , Zarrouk Oumayma , Maaroufi Amel , Kacem Maha , Chaieb Molka Chadli , Ach Koussay

Introduction: Klinefelter syndrome is the most prevalent male chromosomal disorder, characterized by the presence of additional X chromosomes. Most males with Klinefelter syndrome have 47, XXY and normal intelligence. Intellectual disability occurs in males with Klinefelter syndrome variants, who have a higher number of X chromosomes. Here we report a rare case of a 49, XXXXY syndrome revealed by intellectual deficit and pubertal delay.Observation: An 18...